Blackhill Capital’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-400
Closed -$200K – 52
2023
Q1
$200K Hold
400
– – 0.02% 42
2022
Q4
$163K Hold
400
– – 0.02% 46
2022
Q3
$130K Hold
400
– – 0.02% 48
2022
Q2
$140K Hold
400
– – 0.02% 48
2022
Q1
$219K Hold
400
– – 0.02% 48
2021
Q4
$263K Hold
400
– – 0.02% 47
2021
Q3
$249K Hold
400
– – 0.02% 47
2021
Q2
$253K Hold
400
– – 0.02% 48
2021
Q1
$196K Hold
400
– – 0.02% 49
2020
Q4
$200K Sell
400
-200
-33% -$89.5K 0.02% 51
2020
Q3
$236K Hold
600
– – 0.03% 45
2020
Q2
$198K Hold
600
– – 0.03% 49
2020
Q1
$145K Hold
600
– – 0.03% 54
2019
Q4
$157K Hold
600
– – 0.02% 55
2019
Q3
$163K Hold
600
– – 0.03% 60
2019
Q2
$165K Hold
600
– – 0.03% 59
2019
Q1
$134K Hold
600
– – 0.02% 59
2018
Q4
$112K Hold
600
– – 0.02% 56
2018
Q3
$150K Hold
600
– – 0.02% 60
2018
Q2
$131K Hold
600
– – 0.02% 59
2018
Q1
$115K Hold
600
– – 0.02% 60
2017
Q4
$94K Hold
600
– – 0.02% 65
2017
Q3
$93K Hold
600
– – 0.02% 64
2017
Q2
$97K Hold
600
– – 0.02% 63
2017
Q1
$93K Hold
600
– – 0.02% 65
2016
Q4
$70K Hold
600
– – 0.01% 70
2016
Q3
$68K Buy
+600
New +$63.2K 0.01% 72

Other funds holding IDXX

Blackhill Capital's IDXX Position: Q2 2023 in Review

Blackhill Capital sold out of Idexx Laboratories (IDXX) in Q2 2023, closing a stake of 400 shares — an estimated $200K sold.

Blackhill Capital first reported a position in IDXX in Q3 2016 and held it in 27 quarters. The position peaked at $263K in Q4 2021. 1,068 funds tracked by Wall St. Rank hold IDXX as of Q2 2023.

  • Blackhill Capital reported no remaining Idexx Laboratories position as of Q2 2023 after selling out during the quarter.
  • Blackhill Capital sold 400 Idexx Laboratories shares in Q2 2023, an estimated $200K.
  • Blackhill Capital first reported a position in Idexx Laboratories in Q3 2016 and held it in 27 quarters.
  • Blackhill Capital's Idexx Laboratories position peaked at $263K in Q4 2021.
  • 1,068 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2023.

Based on Blackhill Capital's 13F filing for Q2 2023, filed 11 Aug 2023.